glp 1 agonist cardiovascular outcomes Cardiovascular, mortality, and kidney with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Clinical Outcomes with GLP-1 Receptor

Discover Weight Loss GLP-1 Tablets with Orforglipron in India

Learn about the benefits and savings opportunities of the SmithRx Weight Management Pathway.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits

Hear real patient stories, and how Nice Healthcare can support you at every step of your health journey.

Your workforce likely has a growing interest (or curiosity) in GLP-1 medications

We further explore the potential actions of multi-agonist drugs as well as the mechanisms through which gut-brain communication can be used to achieve long-term weight loss without negative side effects